Cargando…

Ultra-Hypofractionated Re-Irradiation with Anti-PD-1 Immunotherapy for Locoregionally Recurrent (after Radical Chemo-Radiotherapy) Non-Small Cell Lung Cancer

SIMPLE SUMMARY: Concurrent administration of anti-PD-1 immunotherapy with one or two fractions of ultra-hypofractionated (8 Gy/fraction) radiotherapy for patients with locoregionally recurrent non-small cell lung cancer (NSCLC) after radical chemo-radiotherapy was examined in a cohort of 11 patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Filippatos, Konstantinos, Koukourakis, Ioannis M., Anevlavis, Stavros, Giaktzidis, Axiotis, Koukourakis, Michael I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605411/ https://www.ncbi.nlm.nih.gov/pubmed/37894449 http://dx.doi.org/10.3390/cancers15205083

Ejemplares similares

Anti-PD-1 immunotherapy with dose-adjusted ultra-hypofractionated re-irradiation in patients with locoregionally recurrent head and neck cancer
por: Koukourakis, Ioannis M., et al.
Publicado: (2023)

Cutaneous squamous-cell carcinoma of the head-neck area refractory to chemo-radiotherapy: benefit from anti-PD-1 immunotherapy
por: Koukourakis, Ioannis M., et al.
Publicado: (2021)

Long-Term Results of Postoperative Hypofractionated Accelerated Breast and Lymph Node Radiotherapy (HypoAR) with Hypofractionated Boost
por: Koukourakis, Ioannis M., et al.
Publicado: (2021)

Prognostic and Predictive Relevance of Tumor-Infiltrating Lymphocytes in Squamous Cell Head–Neck Cancer Patients Treated with Radical Radiotherapy/Chemo-Radiotherapy
por: Koukourakis, Ioannis M., et al.
Publicado: (2022)

Radio-Immunotherapy: A Case Report of ‘Abscopal Hyper-Progression’?
por: Koukourakis, Ioannis M, et al.
Publicado: (2020)

Next-Generation Sequencing Analysis of Mutations in Circulating Tumor DNA from the Plasma of Patients with Head–Neck Cancer Undergoing Chemo-Radiotherapy Using a Pan-Cancer Cell-Free Assay
por: Koukourakis, Michael I., et al.
Publicado: (2023)

Concurrent Hypofractionated Radiotherapy and 5-Fluorouracil for Advanced Sarcomas of the Bone
por: Zambatis, Charalambos, et al.
Publicado: (1998)

Radiobiological analysis of preliminary results of a phase II study of pelvic hypofractionated and accelerated radiotherapy for high-risk prostate cancer patients
por: Nanos, Christos, et al.
Publicado: (2022)

Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma
por: Vordermark, Dirk, et al.
Publicado: (2005)

Sequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancer
por: Bhide, S A, et al.
Publicado: (2008)

High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLC
por: Grambozov, Brane, et al.
Publicado: (2022)

Optimising tumour coverage and organ at risk sparing for hypofractionated re-irradiation in glioblastoma
por: Pagett, Christopher J.H., et al.
Publicado: (2022)

Re-irradiation for locoregionally recurrent tumors of the thorax: a single-institution, retrospective study
por: Sumita, Kiyomi, et al.
Publicado: (2016)

Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancer
por: Yang, Wen-Chi, et al.
Publicado: (2020)

Ectopic Pancreatic Tissue Adherent to the External Gallbladder Wall
por: Koukourakis, Ioannis M., et al.
Publicado: (2018)

Expression of CD47 and SIRPα Macrophage Immune-Checkpoint Pathway in Non-Small-Cell Lung Cancer
por: Giatromanolaki, Alexandra, et al.
Publicado: (2022)

Feasibility of carbon‐ion radiotherapy for re‐irradiation of locoregionally recurrent, metastatic, or secondary lung tumors
por: Hayashi, Kazuhiko, et al.
Publicado: (2018)

Efficacy and toxicity of re-irradiation for esophageal cancer patients with locoregional recurrence: a retrospective analysis
por: Zhao, Kaikai, et al.
Publicado: (2020)

A plesiotherapy technique for the post‐operative treatment of skin cancer using Ir192 microSelectron.
por: Abatzoglou, Ioannis, et al.
Publicado: (2008)

Ultra-Hypofractionation for Whole-Breast Irradiation in Early Breast Cancer: Interim Analysis of a Prospective Study
por: Sigaudi, Valeria, et al.
Publicado: (2022)

Reply: (99m)Tc-labelled Stealth liposomal doxorubicin (Caelyx®) in glioblastomas and metastatic brain tumours
por: Koukourakis, M I
Publicado: (2002)

Low-Dose Radiotherapy for Late-Stage COVID-19 Pneumonia?
por: Koukourakis, Michael I.
Publicado: (2020)

Treatment Outcomes of Re-irradiation in Locoregionally Recurrent Rectal Cancer and Clinical Significance of Proper Patient Selection
por: Chung, Seung Yeun, et al.
Publicado: (2019)

Hypofractionation: The standard for external beam breast irradiation
por: Brunt, Adrian Murray, et al.
Publicado: (2023)

iNOS Expression by Tumor-Infiltrating Lymphocytes, PD-L1 and Prognosis in Non-Small-Cell Lung Cancer
por: Giatromanolaki, Alexandra, et al.
Publicado: (2020)

Tracheal cancer treated with a short course of external and endoluminal radio-chemotherapy combined with cetuximab – a case report
por: Papadopoulou, Aikaterini, et al.
Publicado: (2011)

Hypofractionated Re-irradiation after Maximal Surgical Resection for Recurrent Glioblastoma: Therapeutic Adequacy and Its Prognosticators of Survival
por: Lee, Jeongshim, et al.
Publicado: (2018)

Survival benefit of re-irradiation in esophageal Cancer patients with Locoregional recurrence: a propensity score-matched analysis
por: Hong, Liang, et al.
Publicado: (2018)

Quantitative phase imaging through an ultra-thin lensless fiber endoscope
por: Sun, Jiawei, et al.
Publicado: (2022)

Comprehensive Management of Upper Tract Urothelial Carcinoma
por: Koukourakis, Georgios, et al.
Publicado: (2009)

Efficacy of the Oral Fluorouracil Pro-drug Capecitabine in Cancer Treatment: a Review
por: Koukourakis, Georgios V., et al.
Publicado: (2008)

p53 and angiogenesis in non-small-cell lung cancer.
por: Giatromanolaki, A., et al.
Publicado: (1998)

Advances in Hypofractionated Irradiation-Induced Immunosuppression of Tumor Microenvironment
por: Wang, Yuxia
Publicado: (2021)

Concurrent administration of Docetaxel and Stealth® liposomal doxorubicin with radiotherapy in non-small cell lung cancer : excellent tolerance using subcutaneous amifostine for cytoprotection
por: Koukourakis, M I, et al.
Publicado: (2002)

HIF1α-dependent and independent pathways regulate the expression of PD-L1 in prostate cancer
por: Xanthopoulou, Erasmia T., et al.
Publicado: (2023)

Hypofractionated Stereotactic Re-irradiation and Anti-PDL1 Durvalumab Combination in Recurrent Glioblastoma: STERIMGLI Phase I Results
por: Pouessel, Damien, et al.
Publicado: (2023)

Immune Response and Immune Checkpoint Molecules in Patients with Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy: A Review
por: Koukourakis, Ioannis M., et al.
Publicado: (2023)

Anti-Tumor Immunity and Preoperative Radiovaccination: Emerging New Concepts in the Treatment of Breast Cancer
por: Koukourakis, Ioannis M., et al.
Publicado: (2023)

Prostate Cancer Stem Cells: Biology and Treatment Implications
por: Koukourakis, Ioannis M., et al.
Publicado: (2023)

Radiation-Associated Angiosarcoma of the Breast and Chest Wall Treated with Thermography-Controlled, Contactless wIRA-Hyperthermia and Hypofractionated Re-Irradiation
por: Notter, Markus, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b0dbdfto330oo91gt8nr4duf8b